Kite Testing New Ways To Prime Patients For CAR-T Treatment
Executive Summary
One of the pioneering companies in the CAR-T and TCR space, Kite explained its plan to investigate the benefits of lymphodepletion in a clinical trial of KTE-C19 in NHL. The firm reviewed its pipeline during a recent investor presentation.